299 related articles for article (PubMed ID: 28353124)
1. Nrf2: a potential therapeutic target for diabetic neuropathy.
Kumar A; Mittal R
Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
[TBL] [Abstract][Full Text] [Related]
2. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.
Ganesh Yerra V; Negi G; Sharma SS; Kumar A
Redox Biol; 2013 Aug; 1(1):394-7. PubMed ID: 24024177
[TBL] [Abstract][Full Text] [Related]
4. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats.
Tian R; Yang W; Xue Q; Gao L; Huo J; Ren D; Chen X
Eur J Pharmacol; 2016 Jan; 771():84-92. PubMed ID: 26688570
[TBL] [Abstract][Full Text] [Related]
5. Inflammation: therapeutic targets for diabetic neuropathy.
Zhou J; Zhou S
Mol Neurobiol; 2014 Feb; 49(1):536-46. PubMed ID: 23990376
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.
Negi G; Kumar A; Joshi RP; Sharma SS
Biochem Biophys Res Commun; 2011 Apr; 408(1):1-5. PubMed ID: 21439933
[TBL] [Abstract][Full Text] [Related]
7. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.
Negi G; Kumar A; Sharma SS
J Pineal Res; 2011 Mar; 50(2):124-31. PubMed ID: 21062351
[TBL] [Abstract][Full Text] [Related]
8. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
Maes M; Fišar Z; Medina M; Scapagnini G; Nowak G; Berk M
Inflammopharmacology; 2012 Jun; 20(3):127-50. PubMed ID: 22271002
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway.
Zhang W; Yu H; Lin Q; Liu X; Cheng Y; Deng B
Aging (Albany NY); 2021 Mar; 13(7):10659-10671. PubMed ID: 33770763
[TBL] [Abstract][Full Text] [Related]
11. Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
Agca CA; Tuzcu M; Hayirli A; Sahin K
Food Chem Toxicol; 2014 Sep; 71():116-21. PubMed ID: 24907624
[TBL] [Abstract][Full Text] [Related]
12. Bardoxolone Methyl Ameliorates Hyperglycemia Induced Mitochondrial Dysfunction by Activating the keap1-Nrf2-ARE Pathway in Experimental Diabetic Neuropathy.
Kalvala AK; Kumar R; Sherkhane B; Gundu C; Arruri VK; Kumar A
Mol Neurobiol; 2020 Aug; 57(8):3616-3631. PubMed ID: 32556916
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
Palsamy P; Subramanian S
Biochim Biophys Acta; 2011 Jul; 1812(7):719-31. PubMed ID: 21439372
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.
Patel S; Khan H; Majumdar A
Metab Brain Dis; 2022 Oct; 37(7):2181-2195. PubMed ID: 35616799
[TBL] [Abstract][Full Text] [Related]
15. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
Kim HJ; Vaziri ND
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy.
Negi G; Nakkina V; Kamble P; Sharma SS
Pharmacol Res; 2015 Dec; 102():158-67. PubMed ID: 26432957
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.
Nabavi SF; Barber AJ; Spagnuolo C; Russo GL; Daglia M; Nabavi SM; Sobarzo-Sánchez E
Crit Rev Clin Lab Sci; 2016 Oct; 53(5):293-312. PubMed ID: 26926494
[TBL] [Abstract][Full Text] [Related]
19. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
Kuhad A; Chopra K
Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
Kamboj SS; Vasishta RK; Sandhir R
J Neurochem; 2010 Jan; 112(1):77-91. PubMed ID: 19840221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
